Literature DB >> 18985406

[Data protection and methodological aspects in compiling a routine database from statutory health insurance data for research purposes].

P Ihle1.   

Abstract

Personally identifiable routine data generated by the SHI (statutory health insurance) offer inexpensive and large amounts of data gathered over long periods of observation for use in numerous fields of application including health services research and epidemiology of health care. As a source of medical health information, these data are subject to particular EU data protection directives according to which they can only be used under certain conditions and following careful consideration of the various interests involved. These interests include the protection of personal privacy, on the one hand, and the freedom of research, on the other. As personally identifiable data, these data are fully subject to general and specific data privacy regulations, such as the consideration of intended use; the specification of forms of data processing, duration of use, and group of users; and the development of a data protection concept. If primary data are additionally collected, the patient is to be fully informed about the intended contents of analysis and the use of his/her data in order that informed consent can be provided. Methodological standards such as the verification of completeness and plausibility are also to be met when compiling an insuree database.

Entities:  

Mesh:

Year:  2008        PMID: 18985406     DOI: 10.1007/s00103-008-0647-x

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  2 in total

1.  Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data.

Authors:  Ingrid Schubert; Peter Ihle; Rainer Sabatowski
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

2.  Good Practice Data Linkage (GPD): A Translation of the German Version.

Authors:  Stefanie March; Silke Andrich; Johannes Drepper; Dirk Horenkamp-Sonntag; Andrea Icks; Peter Ihle; Joachim Kieschke; Bianca Kollhorst; Birga Maier; Ingo Meyer; Gabriele Müller; Christoph Ohlmeier; Dirk Peschke; Adrian Richter; Marie-Luise Rosenbusch; Nadine Scholten; Mandy Schulz; Christoph Stallmann; Enno Swart; Stefanie Wobbe-Ribinski; Antke Wolter; Jan Zeidler; Falk Hoffmann
Journal:  Int J Environ Res Public Health       Date:  2020-10-27       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.